Letter by Zhu et al Regarding Article, "Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure"

Hua Zhu¹, Yu-Chen Song^{1

2}, Peng-Zhou Hang¹

Affiliations

¹ Department of Pharmacy, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, China (H.Z., Y.-c.S., P.-z.H.).
² Medical College, Yangzhou University, China (Y.-c.S.).

Comment

Hua Zhu et al. Circulation. 2023.

. 2023 Sep 5;148(10):855-856.

doi: 10.1161/CIRCULATIONAHA.123.065539. Epub 2023 Sep 5.

Hua Zhu¹, Yu-Chen Song^{1

2}, Peng-Zhou Hang¹

¹ Department of Pharmacy, Clinical Medical College, Yangzhou University, Northern Jiangsu People's Hospital, China (H.Z., Y.-c.S., P.-z.H.).
² Medical College, Yangzhou University, China (Y.-c.S.).

No abstract available

Conflict of interest statement

Disclosures None.

Response by Aronsen et al to Letter Regarding Article, "Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure".
Aronsen JM, Skogestad J, Albert I, Melleby AO, Carlson CR. Aronsen JM, et al. Circulation. 2023 Sep 5;148(10):857-858. doi: 10.1161/CIRCULATIONAHA.123.065884. Epub 2023 Sep 5. Circulation. 2023. PMID: 37669357 No abstract available.

Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure.
Skogestad J, Albert I, Hougen K, Lothe GB, Lunde M, Eken OS, Veras I, Huynh NTT, Børstad M, Marshall S, Shen X, Louch WE, Robinson EL, Cleveland JC Jr, Ambardekar AV, Schwisow JA, Jonas E, Calejo AI, Morth JP, Taskén K, Melleby AO, Lunde PK, Sjaastad I, Carlson CR, Aronsen JM. Skogestad J, et al. Circulation. 2023 Apr 18;147(16):1221-1236. doi: 10.1161/CIRCULATIONAHA.121.054168. Epub 2023 Mar 6. Circulation. 2023. PMID: 36876489